Cholera: all 79 studies

Page 1 of 1. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.

• Ondansetron to Prevent Oral Rehydration Failure in Children With CholeraNot yet recruitingNCT07795060Phase 2
• Cholera Control by Case-area Targeted Interventions (CATIs)RecruitingNCT07685574Not applicable
• Extended Dosing Intervals Trial for Oral Cholera Vaccine, KenyaRecruitingNCT07487077Phase 4
• Phase 1b Ascending Dose Study of PanChol in Healthy VolunteersRecruitingNCT07107516Phase 1
• Testing a Scalable Model of the Cholera Hospital-Based Intervention for 7 Days (CHoBI7)RecruitingNCT06498817Not applicable
• Vaccine- and Infection-derived Correlates of Protection for CholeraRecruitingNCT06455852Not applicable
• Cholera-Hospital-Based-Intervention-for-7-Days (CHoBI7) Water, Sanitation, and Hygiene (WASH) Case Area Targeted Intervention (CATI)RecruitingNCT06003816Not applicable
• Co-administration Study of OCV, TCV and MRNot yet recruitingNCT05771779Phase 3
• First in Human Phase 1 Ascending Dose Study of PanChol in Healthy VolunteersRecruitingNCT05657782Phase 1
• Preventative Intervention for Cholera for 7 DaysRecruitingNCT05166850Not applicable
• Impact Study of Cholera Vaccination in Endemic Areas - Clinical SurveillanceRecruitingNCT04853186
• Assessment of a Novel Fixed-dose Combination (FDC) Drug VR-AD-1005 for the Treatment of Acute Watery Diarrhea in CholeraCompletedNCT06193408Phase 2Results posted
• Next Generation ORS: Comparing ORS With Calcium vs Standard ORS in Reducing Severity of Acute Watery DiarrheaCompletedNCT05814042Phase 2/3Results posted
• Water, Sanitation, and Hygiene Mobile Health Messages as an Innovative Tool to Facilitate Behavior ChangeCompletedNCT04816552Not applicableResults posted
• Single Dose Azithromycin to Prevent Cholera in ChildrenCompletedNCT04326478Phase 2Results posted
• Cholera Anti-Secretory Treatment TrialCompletedNCT04150250Phase 2Results posted
• Blood Donor CVD 9000TerminatedNCT03724357Phase 4Results posted
• Immunologic Responses to a Live Attenuated Oral Cholera VaccineCompletedNCT03251495Phase 2Results posted
• VAXCHORA Pediatric Study to Assess Safety and ImmunogenicityCompletedNCT03220737Phase 4Results posted
• Follow-up of Pregnant Women After a Mass Vaccination of Oral Cholera Vaccine (ShancholTM) in Nsanje MalawiTerminatedNCT02499172Not applicableResults posted
• A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older AdultsCompletedNCT02100631Phase 3Results posted
• A Phase 3 Lot to Lot Consistency Study of Live Oral Cholera Vaccine, PXVX0200 in Healthy AdultsCompletedNCT02094586Phase 3Results posted
• Safety and Efficacy Challenge Study of Live Oral Cholera Vaccine Candidate,PXVX0200, to Prevent CholeraCompletedNCT01895855Phase 3Results posted
• Simulation Based Training In Medical StudentsCompletedNCT06929312Not applicable
• Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) VaccinesCompletedNCT06104345Phase 4
• Impact Study of Cholera Vaccination in Endemic Areas - SeroprevalenceCompletedNCT05829772
• To Evaluate Safety of Oral Cholera Vaccine Hillchol® (BBV131)Status unknownNCT05732766Phase 3
• Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy AdultsCompletedNCT05559983Phase 1
• A Phase III Randomized, Modified Double-blind, Multi-centric, Comparative Study, to Evaluate the Non-inferiority of Immunogenicity and Safety of Hillchol® (BBV131)to Shanchol™ Along With Lot-to-lot Consistency of Hillchol®(BBV131).Status unknownNCT05507229Phase 3
• Immune Response to a Delayed Second Dose of Oral Cholera VaccineStatus unknownNCT05453253Phase 4
• Immune Non-Inferiority, Safety and Lot-to-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shanchol™CompletedNCT04760236Phase 3
• Immunological Characteristics of a Population at Risk of Cholera After Oral Cholera Vaccine (CHOVAXIM)CompletedNCT04423159Not applicable
• Cholera-Hospital-Based-Intervention-for-7-daysCompletedNCT04008134Not applicable
• Immunogenicity of Cholera Vaccine in Children With IBDCompletedNCT03998449Not applicable
• Extended Dose Intervals With Oral Cholera Vaccine in CameroonCompletedNCT03719066Phase 2
• Immunogenicity of Co-administered Oral Polio Vaccine and Oral Cholera VaccineStatus unknownNCT03581734Phase 3
• Effect of Extended Dose Intervals on the Immune Response to Oral Cholera VaccineCompletedNCT03373669Phase 4
• Safety of An Oral O1 / O139 Cholera Vaccine (Enteric Capsules)CompletedNCT03237663Phase 1
• Impact Evaluation of Urban Water Supply Improvements on Cholera and Other Diarrhoeal Diseases in Uvira, Democratic Republic of CongoCompletedNCT02928341Not applicable
• Evaluation of a Pilot Program to Introduce Cholera Vaccine in Haiti as Part of Global Cholera Control EffortsCompletedNCT02864433
• Safety and Immunogenicity of Locally Manufactured New (HL-OCV) Oral Cholera VaccineCompletedNCT02823899Phase 1/2
• Safety and Immunogenicity of Locally Manufactured Oral Cholera VaccineCompletedNCT02742558Phase 2
• Cholera Vaccine Investment Strategy in BangladeshCompletedNCT02727855
• Safety and Immunogenicity of a New Formulation of Euvichol®Status unknownNCT02502331Phase 3
• A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in Dominican RepublicCompletedNCT02434822Phase 3
• Effect of Raw Milk on the Immune Response Upon Cholera VaccinationCompletedNCT02238548Not applicable
• PXVX0200 (CVD103-HgR) vs Shanchol in MaliCompletedNCT02145377Phase 2
• Efficacy of iOWH032 in Dehydrating CholeraWithdrawnNCT02111304Phase 2
• Single Dose Oral Cholera Vaccine Study in Dhaka, BangladeshCompletedNCT02027207Phase 3
• A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the PhilippinesCompletedNCT01949675Phase 4
• High Amylose Maize Starch for Treatment of CholeraTerminatedNCT01823952
• PK Study of iOWH032 in Adult Male/Female Healthy Volunteers & Adult Males With CholeraCompletedNCT01823939Phase 1
• Oral Cholera Vaccine Delivery in Rural BangladeshCompletedNCT01811771Not applicable
• To Determine the Safety and Immunogenicity of an Oral(Whole Cell) Euvichol Cholera Vaccine in Healthy Adult MenCompletedNCT01707537Phase 1
• Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200CompletedNCT01585181Phase 1
• Evaluation of a Boosting Regimen With Oral Cholera VaccineCompletedNCT01579448Phase 4
• Bridging Study for Killed Oral Cholera Vaccine in EthiopiaCompletedNCT01524640Phase 4
• Effectiveness of a Bivalent Killed Whole Cell Based Oral Cholera VaccineStatus unknownNCT01508507
• Pilot Introduction of Oral Cholera Vaccine in Orissa, IndiaCompletedNCT01365442
• Introduction of Cholera Vaccine in BangladeshCompletedNCT01339845Not applicable
• Study of Alternative Vaccination Schedule of Oral Cholera VaccineCompletedNCT01233362Phase 2
• Studies of Immune Responses to Orally Administered Vaccines in Developing CountryCompletedNCT01019083Phase 1/2
• A Study to Evaluate Safety and Immunogenicity of the Bivalent Killed Whole Cell Oral Cholera Vaccine in Adults and ChildrenCompletedNCT00760825Phase 4
• Safety and Immunogenicity of Single Dose Choleragarde® in HIV-Seropositive AdultsCompletedNCT00741637Phase 2
• Ciprofloxacin Multiple Dose for Adult CholeraCompletedNCT00741052Phase 3
• Mass Oral Cholera Vaccination in ZanzibarCompletedNCT00709410Not applicable
• Efficacy of Benefiber-Added, Reduced-Osmolarity WHO-ORS in the Treatment of Cholera in AdultsCompletedNCT00672308Phase 2
• Safety and Immunogenicity of Peru-15 Vaccine When Given With Measles Vaccine in Healthy Indian and Bangladeshi InfantsTerminatedNCT00624975Phase 2
• Safety and Immunogenicity of a Killed Oral Cholera Vaccine in InfantsStatus unknownNCT00548054Phase 2
• Effect of Probiotic on Immunogenicity of Oral Cholera VaccineCompletedNCT00464867Not applicable
• Immunogenicity of One Versus Two Doses of Killed Oral Cholera VaccineCompletedNCT00419133Phase 2
• Immunity to Human Cholera in BangladeshCompletedNCT00401934
• Protective Immunity to Human Cholera in BangladeshCompletedNCT00349999
• Randomized Controlled Trial of Killed Oral Cholera Vaccine in KolkataCompletedNCT00289224Phase 3
• Single Dose Azithromycin in the Treatment of Adult CholeraCompletedNCT00229944Phase 3
• Zinc Supplementation in Cholera PatientsCompletedNCT00226616Phase 3
• Single Dose Ciprofloxacin in the Treatment of Childhood Cholera:Randomized Controlled Clinical TrialCompletedNCT00142272Phase 3
• Safety and Immunogenicity of a New Formulation of a Bivalent Killed, Whole-Cell Oral Cholera VaccineCompletedNCT00128011Phase 2
• Safety and Immunogenicity of Oral Cholera Vaccine in KolkataCompletedNCT00119197Phase 2

← Cholera overview